Novo Nordisk A/S shares fell as a US rivals comments on an experimental obesity drug gave rise to concerns about potential new competition in the rapidly growing field.
The stock slid as much as 5.3… [read more]
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Password recovery
Recover your password
A password will be e-mailed to you.
Novo Slides as Amgen Fuels Obesity Drug Competition Fears – Bloomberg
Date:
More like thisRelated
Walmart Will Cut Relocate Hundreds of Corporate Jobs WSJ Says – Bloomberg
Walmart Inc. is axing hundreds of corporate jobs and...
PS5 Sets Sales Record but Just Misses Target Sony Predicts Further Decline This Year – IGN
PlayStation 5 sales hit a peak with 20.8 million...
Job search giant lays off dozens at Bay Area office – SFGATE
FILE: Indeed CEO Chris Hyams at a press conference...
Macron Leaves Door Open for Big M&A Plan for Europe’s Economy Revival – Bloomberg
President Emmanuel Macron said he would be open to...